Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Becton Dickinson and Co (NYSE:BDX)

177.13
Delayed Data
As of 3:59pm ET
 -2.37 / -1.32%
Today’s Change
128.87
Today|||52-Week Range
181.76
+14.95%
Year-to-Date
3 Attractive Income Stocks Whose Dividends Could Double
11:58am / MotleyFool.com - Paid Partner Content
Becton, Dickinson (BDX) Introduces New Vascular Dressing
Sep 19 / Zacks.com - Paid Partner Content
Becton (BDX) to Expand Syringe Capacity at Holdrege Facility
Sep 23 / Zacks.com - Paid Partner Content
Avery Dennison (AVY) & BD Launch New Vascular Dressings
Sep 19 / Zacks.com - Paid Partner Content
Becton, Dickinson (BDX) Launch Wireless Diagnostic Device
Sep 22 / Zacks.com - Paid Partner Content
Becton, Dickinson (BDX) Gets USFDA Clearance for BD MAX
Sep 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close179.50
Today’s open178.53
Day’s range176.30 - 178.53
Volume31,719
Average volume (3 months)831,250
Market cap$38.2B
Dividend yield1.49%
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)-44.07%
Earnings growth (this year)+19.78%
Earnings growth (next 5 years)+11.20%
Revenue growth (last year)+21.94%
P/E ratio33.8
Price/Sales2.68
Price/Book5.28

Competitors

 Today’s
change
Today’s
% change
BSXBoston Scientific Co...+0.03+0.13%
ZBHZimmer Biomet Holdin...-1.44-1.12%
BCRC R Bard Inc-2.09-0.91%
DXCMDexCom Inc-0.77-0.82%
Data as of 3:59pm ET, 09/26/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$2.10
Annual revenue (last year)$10.3B
Annual profit (last year)$695.0M
Net profit margin6.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Vincent A. Forlenza
EVP, Chief Financial &
Administrative Officer
Christopher R. Reidy
Corporate headquarters
Franklin Lakes, New Jersey

Forecasts

Search for Jobs